Trial Profile
Comprehensive and individualized trial of teraprevir/peginterferon alpha-2b/ribavirin for chronic hepatitis C patients with genotype 1 and high viral loads
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 01 Sep 2015
Price :
$35
*
At a glance
- Drugs Telaprevir (Primary) ; Peginterferon alfa-2b; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- Acronyms CITATION
- 30 Aug 2015 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 04 May 2013 New trial record